Search results
Is Sanofi SA (NASDAQ:SNY) the Best International Pharmaceutical Dividend Stock?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since Sanofi SA...
Regeneron, Sanofi Get Expanded FDA OK for Kevzara in Polyarticular Juvenile Idiopathic Arthritis
Morningstar· 3 days agoBy Colin Kellaher Regeneron Pharmaceuticals and Sanofi have won expanded Food and Drug Administration approval of their arthritis drug Kevzara for certain ...
Sanofi (NASDAQ:SNY) Shares Acquired by Putnam Investments LLC
ETF DAILY NEWS· 2 days agoPutnam Investments LLC boosted its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 25.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,342,709 ...
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
Zacks via Yahoo Finance· 3 days agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that the FDA has approved a...
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
Motley Fool via Yahoo Finance· 2 days agoThe outcome of this initiative is impossible to predict, but Sanofi undoubtedly deserves a look if...
Regeneron CEO Leonard Schleifer sells over $25 million in company stock By Investing.com
Investing.com· 10 hours agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) has reported a series of transactions by...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 7 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
JD Supra: Breaking: Third Circuit Declares Mallinckrodt’s Future Royalty Payment Obligations...
JD Supra· 2 days agoOn April 25, the US Court of Appeals for the Third Circuit issued its precedential opinion in Mallinckrodt v. Sanofi-Aventis, Case No. 23-1111, reminding everyone that “creditors ...
Exploring Three Top Dividend Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance· 1 day agoIn recent trading sessions, the French stock market has shown resilience, with the CAC 40 Index...
Why Regeneron Stock Finally Joined The 1,000-Club
Investor's Business Daily· 1 day agoEnthusiasm is growing for a looming approval in COPD treatment.